Parnell Pharmaceuticals Holdings Revenue and Competitors

Location

$20M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Parnell Pharmaceuticals Holdings's estimated annual revenue is currently $12.3M per year.(i)
  • Parnell Pharmaceuticals Holdings's estimated revenue per employee is $137,764
  • Parnell Pharmaceuticals Holdings's total funding is $20M.

Employee Data

  • Parnell Pharmaceuticals Holdings has 89 Employees.(i)
  • Parnell Pharmaceuticals Holdings grew their employee count by 7% last year.

Parnell Pharmaceuticals Holdings's People

NameTitleEmail/Phone
1
VP, RegulatoryReveal Email/Phone
2
VP Digital TechnologyReveal Email/Phone
3
SVP FinanceReveal Email/Phone
4
SVP & President US Operations at Parnell - Living ScienceReveal Email/Phone
5
VP TechnologyReveal Email/Phone
6
VP Strategic MarketingReveal Email/Phone
7
VP US Commercial OperationsReveal Email/Phone
8
VP New Product & InnovationReveal Email/Phone
9
Supply Chain DirectorReveal Email/Phone
10
Associate DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.3M5610%N/AN/A
#2
$24.1M120-2%N/AN/A
#3
$6M307%N/AN/A
#4
$29.7M14811%N/AN/A
#5
$4.6M235%N/AN/A
#6
$75M3731%N/AN/A
#7
$22.9M1141%N/AN/A
#8
$4.4M22-4%$509KN/A
#9
$12.3M897%$20MN/A
#10
$3.6M18-5%N/AN/A
Add Company

What Is Parnell Pharmaceuticals Holdings?

Parnell is a fully integrated veterinary pharmaceutical company dedicated to finding animal health solutions that matter. With a world class FDA accredited manufacturing facility in Sydney and operations in the USA, Canada, Middle East and Asia-Pacific, Parnell is one of the few companies committed to continued development of innovative products at the highest standard. Parnell has market leading products in Dairy and Beef Cattle Reproduction and Osteoarthritis treatments for Dogs and Horses. Our R&D pipeline spans Cattle Reproduction, Cattle Mastitis, Anesthetics for Dogs & Cats, Laminitis treatment for Horses, and Orthopedic treatments for multiple species.

keywords:N/A

$20M

Total Funding

89

Number of Employees

$12.3M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Parnell Pharmaceuticals Holdings News

2022-02-22 - Notice to Shareholders of Parnell Pharmaceuticals Holdings, Ltd ...

SYDNEY, Dec. 15, 2017 /PRNewswire/ -- Parnell Pharmaceuticals Holdings Ltd. (OTC PINK:PARNF) company Director, Robert Joseph is providing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.4M90-14%N/A
#2
$14.9M90-3%N/A
#3
$22.5M998%N/A
#4
$21.4M10224%N/A
#5
$27.8M10321%N/A